You have searched for "Benefits"
Showing 1-10 of 10000
PARIS (Reuters) - The European Union's COVID-19 recovery response is robust and does not fall short when compared with the United States' $1.9 trillion recovery plan, European Council President Charles Michel told Les Echos newspaper.
(Reuters) - Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson's COVID-19 vaccine.
PETALING JAYA: The aid and initiatives for the urban poor and vulnerable groups under the recent Pemerkasa stimulus programme are a welcome effort that’s much-lauded by the B40 community.
SUBANG JAYA: The latest information concerning the use of the AstraZeneca vaccine will be reviewed and presented in a meeting soon, says Khairy Jamaluddin.
GEORGE TOWN: After a tough year grappling with the Covid-19 pandemic, many hawkers have now unlocked a new revenue path in online order and delivery.
(Reuters) - Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries of the shot amid concern about a possible very small risk of rare blood clots.
ZURICH (Reuters) - Europe's drug regulator on Wednesday said it had found a possible link between AstraZeneca's COVID-19 vaccine and very rare blood clots in adults who received the shot. Britain recommended people under 30 get an alternative COVID-19 vaccine if possible.
(Reuters) - Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world.
KUALA LUMPUR: The Transport Ministry is examining issues and proposals brought up to aid the country's bus industry, says Datuk Seri Dr Wee Ka Siong.
(Corrects to 86,000 kyats in paragraph 25)